The overall survival of patients with BM-MM primarily depends on the number of metastases and pretreatment level of LDH. In the case of a single brain metastasis, stereotactic radiotherapy or neurosurgical metastasectomy is by far the most important factor for improving survival.
Division of Dermatooncology, Department of Dermatology, University Hospital Tuebingen, Tuebingen, Germany.
Cancer. 2011 Apr;117(8):1697-703
© Galenicom 1999-2013